NO20032973L - Excitatory amino acid receptor antagonists - Google Patents
Excitatory amino acid receptor antagonistsInfo
- Publication number
- NO20032973L NO20032973L NO20032973A NO20032973A NO20032973L NO 20032973 L NO20032973 L NO 20032973L NO 20032973 A NO20032973 A NO 20032973A NO 20032973 A NO20032973 A NO 20032973A NO 20032973 L NO20032973 L NO 20032973L
- Authority
- NO
- Norway
- Prior art keywords
- amino acid
- receptor antagonists
- acid receptor
- excitatory amino
- excitatory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26001401P | 2001-01-05 | 2001-01-05 | |
| PCT/US2001/044715 WO2002053561A1 (en) | 2001-01-05 | 2001-12-20 | Excitatory amino acid receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20032973L true NO20032973L (en) | 2003-06-27 |
| NO20032973D0 NO20032973D0 (en) | 2003-06-27 |
Family
ID=22987455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20032973A NO20032973D0 (en) | 2001-01-05 | 2003-06-27 | Excitatory amino acid receptor antagonists |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1351955A1 (en) |
| JP (1) | JP2004520335A (en) |
| KR (1) | KR20030066797A (en) |
| CN (1) | CN1484642A (en) |
| AR (1) | AR035679A1 (en) |
| BR (1) | BR0116672A (en) |
| CA (1) | CA2431545A1 (en) |
| CZ (1) | CZ20031856A3 (en) |
| DZ (1) | DZ3460A1 (en) |
| EA (1) | EA200300770A1 (en) |
| EC (1) | ECSP034682A (en) |
| HR (1) | HRP20030544A2 (en) |
| HU (1) | HUP0302528A2 (en) |
| IL (1) | IL156138A0 (en) |
| MX (1) | MXPA03005981A (en) |
| NO (1) | NO20032973D0 (en) |
| NZ (1) | NZ525821A (en) |
| PE (1) | PE20020792A1 (en) |
| PL (1) | PL361934A1 (en) |
| SK (1) | SK8242003A3 (en) |
| TW (1) | TW591023B (en) |
| WO (1) | WO2002053561A1 (en) |
| ZA (1) | ZA200304311B (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| SK11812000A3 (en) * | 1998-02-06 | 2001-08-06 | Smithkline Beecham Plc | Salts of paroxetine |
| GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
| DZ3209A1 (en) * | 1999-07-06 | 2001-01-11 | Lilly Co Eli | Selective iGLuR5 receptor antagonists used in the treatment of migraine. |
-
2001
- 2001-12-20 CN CNA018217508A patent/CN1484642A/en active Pending
- 2001-12-20 HU HU0302528A patent/HUP0302528A2/en unknown
- 2001-12-20 EP EP01995980A patent/EP1351955A1/en not_active Withdrawn
- 2001-12-20 NZ NZ525821A patent/NZ525821A/en unknown
- 2001-12-20 IL IL15613801A patent/IL156138A0/en unknown
- 2001-12-20 SK SK824-2003A patent/SK8242003A3/en unknown
- 2001-12-20 PL PL01361934A patent/PL361934A1/en not_active Application Discontinuation
- 2001-12-20 CA CA002431545A patent/CA2431545A1/en not_active Abandoned
- 2001-12-20 KR KR10-2003-7008977A patent/KR20030066797A/en not_active Application Discontinuation
- 2001-12-20 BR BR0116672-7A patent/BR0116672A/en not_active IP Right Cessation
- 2001-12-20 JP JP2002554680A patent/JP2004520335A/en active Pending
- 2001-12-20 EA EA200300770A patent/EA200300770A1/en unknown
- 2001-12-20 WO PCT/US2001/044715 patent/WO2002053561A1/en not_active Application Discontinuation
- 2001-12-20 CZ CZ20031856A patent/CZ20031856A3/en unknown
- 2001-12-20 DZ DZ013460A patent/DZ3460A1/en active
- 2001-12-20 MX MXPA03005981A patent/MXPA03005981A/en unknown
-
2002
- 2002-01-04 TW TW091100071A patent/TW591023B/en not_active IP Right Cessation
- 2002-01-04 AR ARP020100030A patent/AR035679A1/en not_active Application Discontinuation
- 2002-01-04 PE PE2002000003A patent/PE20020792A1/en not_active Application Discontinuation
-
2003
- 2003-06-02 ZA ZA200304311A patent/ZA200304311B/en unknown
- 2003-06-27 NO NO20032973A patent/NO20032973D0/en not_active Application Discontinuation
- 2003-07-03 EC EC2003004682A patent/ECSP034682A/en unknown
- 2003-07-03 HR HR20030544A patent/HRP20030544A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20031856A3 (en) | 2003-09-17 |
| CA2431545A1 (en) | 2002-07-11 |
| CN1484642A (en) | 2004-03-24 |
| NZ525821A (en) | 2004-07-30 |
| IL156138A0 (en) | 2003-12-23 |
| BR0116672A (en) | 2003-09-23 |
| NO20032973D0 (en) | 2003-06-27 |
| ZA200304311B (en) | 2004-09-02 |
| AR035679A1 (en) | 2004-06-23 |
| WO2002053561A1 (en) | 2002-07-11 |
| PL361934A1 (en) | 2004-10-18 |
| JP2004520335A (en) | 2004-07-08 |
| HUP0302528A2 (en) | 2003-11-28 |
| PE20020792A1 (en) | 2002-09-06 |
| MXPA03005981A (en) | 2003-09-10 |
| TW591023B (en) | 2004-06-11 |
| EP1351955A1 (en) | 2003-10-15 |
| DZ3460A1 (en) | 2002-07-11 |
| HRP20030544A2 (en) | 2004-08-31 |
| ECSP034682A (en) | 2003-08-29 |
| KR20030066797A (en) | 2003-08-09 |
| EA200300770A1 (en) | 2003-10-30 |
| SK8242003A3 (en) | 2004-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20051871D0 (en) | Opioid receptor antagonists | |
| DK1446379T3 (en) | Arylanilin-beta2-adrenergic receptor agonists | |
| IS7583A (en) | Calcitonin gene-related peptide receptor antagonists | |
| DK1405852T3 (en) | diamine | |
| IS7096A (en) | Replaced urothelial peptide Y Y5 receptor antagonists | |
| DE60216229D1 (en) | IL-8 receptor antagonists | |
| DK1163239T3 (en) | Modified amino acid amides as CGRP antagonists | |
| BR0207810A (en) | peptide deformylase inhibitors | |
| ATE469875T1 (en) | NK1 ANTAGONISTS | |
| DE60222693D1 (en) | NK1 ANTAGONISTS | |
| ATE392418T1 (en) | SUBSTITUTED FLUORALKOXYPHENYLSULFONYL UREAS | |
| NO20042338L (en) | Unsaturated 1-aminoalkylcyclohexane NMDA, 5HT3 and neuronal nicotinic acid receptor antagonists | |
| DE60226419D1 (en) | SOMATOSTATIN ANTAGONISTS | |
| DK1368032T3 (en) | Excitatory amino acid receptor antagonists | |
| NO20032963D0 (en) | peptide | |
| EE200300335A (en) | Histamine receptor antagonists | |
| NO20032973L (en) | Excitatory amino acid receptor antagonists | |
| ATE370932T1 (en) | CCR-3 RECEPTOR ANTAGONISTS VII | |
| FR2847624B1 (en) | SPHERICAL JOINT | |
| AU2002227020A1 (en) | Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists | |
| NO20053512D0 (en) | IL-8-like proteins | |
| DE60209885D1 (en) | CRF RECEPTOR ANTAGONISTS | |
| AU2002228736A1 (en) | Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists | |
| NO20052608D0 (en) | Midkin-like protein | |
| SE0100442D0 (en) | Merge nails |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |